Final Height Following Growth Hormone Treatment of Idiopathic Growth Hormone Deficiency in KIGS Wayne S Cutfield, Anders Lindberg, Pierre Chatelain, David.

Slides:



Advertisements
Similar presentations
Trends in the Diagnosis and Treatment of Short Stature as Revealed by KIGS Pierre Chatelain KIGS 10 Year Book, 1999.
Advertisements

Normal distribution. An example from class HEIGHTS OF MOTHERS CLASS LIMITS(in.)FREQUENCY
Growth Hormone Treatment in Some Types of Skeletal Dysplasia and in Some Syndromes with Short Stature in KIGS Olcay Neyzi KIGS 10 Year Book, 1999.
Turner Syndrome Presentation to TCGI Conference 2008.
Slides presented by the FDA at the Endocrinologic & Metabolic Drugs Advisory Committee meeting on June 10, 2003.
GH Treatment in Children in Remission from Leukaemia and Lymphoma in KIGS Nikolaus Stahnke KIGS 10 Year Book, 1999.
Growth Hormone Treatment in Children with Malignant Cranial Tumours in KIGS Michael B Ranke and David A Price KIGS 10 Year Book, 1999.
Early Loss of the Glucagon Response to Hypoglycemia in Adolescents With Type 1 Diabetes Featured Article: Aris Siafarikas, F.R.A.C.P., M.D., Robert J.
Langerhans Cell Histiocytosis: Growth Hormone Treatment over 3 years in KIGS Simon J Howell KIGS 10 Year Book, 1999.
Risk of Obesity in ALL survivors Dr. Abdulmajeed AlSubaihin, MBBS, FRCPC.
Normal growth Dr fatholahpour pediatric endocrinologist
Defining Insulin-Like Growth Factor-I Deficiency
Kin 304 Descriptive Statistics & the Normal Distribution
Short Stature in Noonan Syndrome: Demography and Response to Growth Hormone Treatment in KIGS Barto J Otten KIGS 10 Year Book, 1999.
Development of the KIGS Model for Predicting Growth Response to Growth Hormone Replacement Therapy in Children with Idiopathic Growth Hormone Deficiency.
Continuing the Treatment of Growth Hormone Deficiency During the Transition from Childhood into Adulthood Michael B Ranke and John P Monson KIGS 10 Year.
Growth Hormone Treatment in Children with Intrauterine Growth Retardation and Silver-Russell Syndrome Pierre Chatelain KIGS 10 Year Book, 1999.
Growth Hormone Treatment of Children with Prader-Willi Syndrome as Reported to KIGS: First-Year Growth Hormone E Martin Ritzén KIGS 10 Year Book, 1999.
Short stature Dr ali mazaheri MD.
Early Childhood Epilepsy Severity Scale (E-CHESS) Humphrey A et al. Epilepsy Research (2008) 79: 139— Frequency of seizures 2. Time period over.
0.24→0.37 mg/kg/week (▲) and 0.37 mg/kg/week ().
Copyright © American Speech-Language-Hearing Association
ERT, estrogen replacement therapy
Figure 2 Top panel shows mean (SE) differences in near-final height (cm) (n = 71) in the AI, GH, and AI/GH groups regardless of length of treatment (n.
Figure 1. Serum B-ALP levels in normal male (•) and female (○) children as a function of age. Serum B-ALP levels were increased during infancy and puberty.
The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD)  S. Malik, S.F. Ahmed, M.L. Wilson, N. Shah, S. Loganathan,
Copyright © 2002 American Medical Association. All rights reserved.
Figure 1. Serum concentrations of IGF-I (A), IGF-II (B), IGFBP-3 (C), and ALS (D) throughout life in GHD (closed circles) and healthy control (open circles)
Fig. 4. Relationships of changes in CRP or SAA to changes in body weight and insulin resistance. For each comparison the regression line is shown (solid.
Expression analyses of KLK7 mRNA in the brains of AD patients
A: Box plot comparing the average changes in HbA1c between surgery and medical/lifestyle treatments in the first reports of the 11 RCTs published to date.
Plasma active glucagon-like peptide-1 (GLP-1) response in patients with type  2 diabetes during the liquid high-fat meal test at baseline, 12 weeks and.
Differences in the glycated hemoglobin (HbA1c) levels.
NMDA-Receptor Antagonists in Neuropathic Pain
Figure 3 Age, pretreatment, sex, and leukopenia do not influence CD19+ cell repopulation Age, pretreatment, sex, and leukopenia do not influence CD19+
Box-And-Whisker Plots
Box and Whisker Plot of the Distribution of Perceived Stress Scores for TMD Controls and TMD CasesThe horizontal line within the box is the median value.
M. Kraemer, C. Rode, V. Wizemann  Kidney International 
Relationship between karyotype and basal characteristics at GH start
Fig.1. The dose of GH administered to patients in different age groups after 1 year of GH replacement therapy. Data are shown as mean, median and 10th-90th.
Bradley A. Ford, Daniel W. Coyne, Charles S. Eby, Mitchell G. Scott 
Individual genes exhibit distinct stage-specific expression among female gametocytes. Individual genes exhibit distinct stage-specific expression among.
 Height SDS  Weight SDS
Individual genes exhibit distinct female-enriched expression patterns.
Comparison of absolute counts for a, b) white blood cells (WBC), c, d) neutrophils, e, f) monocytes, and g, h) eosinophils for 100 patients with lymphangioleiomyomatosis.
Lesson
Intensity of statistical methods and reporting subdivided by the journal groups. Intensity of statistical methods and reporting subdivided by the journal.
Box-And-Whisker Plots
Box-And-Whisker Plots
CI, confidence interval (95%)
Growth rate (cm/yr) Estrogen at age 12 Estrogen at age 15
Between-country and within-country variability in the number of nursing care activities left undone—composite score in 488 European hospitals. Between-country.
Identification of highly variable transcripts.
Change in 6 min walk distance from baseline to each follow-up time for subjects randomised to CABG and to medical therapy alone. The median change and.
Valeria Calvi et al. JACEP 2017;j.jacep
Wnt/β-catenin signalling stabilises and enhances spontaneous symmetry-breaking and polarisation events in gastruloids. Wnt/β-catenin signalling stabilises.
Comparison of mean Schirmer tear test (STT)-1 results (mm/min) in 30 dogs before (STT-1a) and after (STT-1b) administration of acepromazine (0.02 mg/kg)
Use of a high-fidelity simulator to develop testing of the technical performance of novice anaesthetists†   F.C. Forrest, M.A. Taylor, K. Postlethwaite,
MSK1 is necessary for BDNF-dependent CREB phosphorylation in area CA1.
Breadth of antigen response as a correlate of protection.
Similar neurobehavioral outcome after valve or coronary artery operations despite differing carotid embolic counts  Michael J. Neville, MDa, John Butterworth,
Descriptive statistics for groups:
Fig. 3 DEP screening indicates positive correlation between S
Time to onset of hypothyroidism after first treatment with immune checkpoint inhibitors in the combination therapy and monotherapy groups. Time to onset.
Baseline characteristics of the participants according to study group.
chemistry that are involved in peer group
Sodium consumption (mg/day) at baseline by demographic characteristics in a cohort of self-referred patients with type 2 diabetes. Sodium consumption (mg/day)
Inhibition of CD20 mRNA expression by ibrutinib correlates with reduced NF-κB activity. Inhibition of CD20 mRNA expression by ibrutinib correlates with.
Box and whisker plots of pre-trilostane, three-hour post-trilostane and post-adrenocorticotrophic hormone (ACTH) cortisol concentrations divided into two.
Intersubject distribution of eGFR slope (left) and mGFR slope (right).
Presentation transcript:

Final Height Following Growth Hormone Treatment of Idiopathic Growth Hormone Deficiency in KIGS Wayne S Cutfield, Anders Lindberg, Pierre Chatelain, David A Price, Kerstin Albertsson-Wikland, Patrick Wilton, and Michael B Ranke on behalf of the KIGS International Board KIGS 10 Year Book, 1999

W Cutfield - KIGS 10 Year Book, 1999 Baseline characteristics of patients with idiopathic GHD prior to commencement of GH therapy a MPH, mid-parental height; SDS, standard deviation score * p<0.01 a Values expressed as medians (10th - 90th percentiles)

W Cutfield - KIGS 10 Year Book, 1999 GH treatment regimens and auxological characteristics of patients with idiopathic GHD who have achieved final height a MPH, mid-parental height; SDS, standard deviation score * p<0.01 a Values expressed as medians (10th - 90th percentiles)

W Cutfield - KIGS 10 Year Book, 1999 Final height achieved by male subjects with idiopathic growth hormone deficiency (1/2) Means ( ), +2 SD ( ), and -4 SD ( ).

Final height achieved by female subjects with idiopathic growth hormone deficiency W Cutfield - KIGS 10 Year Book, 1999 (2/2) Means ( ), +2 SD ( ), and -4 SD ( ).

W Cutfield - KIGS 10 Year Book, 1999 Comparison of patients with spontaneous onset of puberty and those with induced puberty for whom auxological data were available at onset of puberty (medians) MPH, mid-parental height; SDS, standard deviation score, * p<0.01

MPH, mid-parental height ; NS, not significant W Cutfield - KIGS 10 Year Book, 1999 Relation of pretreatment and treatment variables to final height based on simple linear correlations

Influence of mid-parental height on final height in the National Cooperative Growth Study (NCGS) a and in KIGS subjects W Cutfield - KIGS 10 Year Book, 1999 a NCGS data from Blethen et al (1997)

Difference in height SDS between idiopathic GH- deficient male subjects with induced or with spontaneous puberty at start of GH treatment, onset of puberty and final height W Cutfield - KIGS 10 Year Book, 1999 Spontaneous Induced GH start Spontaneous Induced Pubertal onset Spontaneous Induced Final height Height (SDS) Data are shown as 25th and 75 percentiles (box plots), medians (rules) and means (dots), with whiskers at the 10th and 90th percentiles

Difference in height SDS between idiopathic GH- deficient female subjects with induced or with spontaneous puberty at start of GH treatment, onset of puberty and final height W Cutfield - KIGS 10 Year Book, 1999 Spontaneous Induced GH start Spontaneous Induced Pubertal onset Spontaneous Induced Final height Height (SDS) Data are shown as 25th and 75 percentiles (box plots), medians (rules) and means (dots), with whiskers at the 10th and 90th percentiles